Given the increased prevalence of allergy and asthma, identifying the molecular pathways that modulate the response of type 2 innate lymphoid cells (ILC2s) to alarmins is an important area of inquiry. Damaged or stressed epithelial cells produce alarmin cytokines, such as IL-25 and IL-33, which activate ILC2s [1] [2] [3] [4] [5] . Activated ILC2s initiate allergic tissue inflammation at mucosal surfaces, in part by rapidly producing effector cytokines, such as IL-5 and IL-13 [6] [7] [8] . ILC2s also maintain tissue homeostasis by promoting epithelial cell proliferation, survival, and barrier integrity 9 . However, the factors that balance homeostatic and inflammatory ILC2 responses are unknown, as is whether distinct ILC2 subsets mediate these effects.
It is challenging to distinguish homeostatic from pro-inflammatory ILC2s, since there are few known markers of these functional states. Single-cell genomics, especially single-cell RNA-sequencing (scRNA-seq) 10, 11 , can identify such diversity, both when changes in cell states are continuous across a population 12 and when there are discrete subpopulations of varying sizes, including in intestinal ILCs [13] [14] [15] .
Alarmins induce heterogeneity in ILC2s
To define the transcriptional landscape of lung-resident ILCs, we collected 24,187 high-quality, droplet-based scRNA-seq profiles of ILCs (IL-7Ra + CD90 + and lacking lineage markers) at steady state and after in vivo activation by IL-25 or IL-33 (Fig. 1a , Extended Data Fig. 1a-c) . We scored cells based on expression of ILC subset-specific signature genes (after condition-specific normalization, Methods), and classified cells as ILC1, ILC2, ILC3, 'mixed' , or 'none' if no score was sufficiently high (Extended Data Fig. 1d -f, Methods). Mixed profile ILCs could either represent a transient or plastic transcriptional state or cell doublets. Expression of key signature genes (for example, Tbx21, Il1rl1, Rorc) supported our cell classification (Extended Data ; IL-25, P < 8.4 × 10
−8
). Alarmin treatment induced unique gene expression programs, as suggested by the relationship between the expression profiles of cells from different treatment conditions, independent of experimental batch (Fig. 1a, Extended Data Fig. 1h ). IL-25 and IL-33 both upregulated genes associated with ILC2 activation, including Il5, Klrg1, and Arg1, while other genes, such as Areg, were preferentially induced by one alarmin but not the other (Extended Data Fig. 1i ) 2, 16 . We partitioned transcriptionally distinct ILCs into 11 clusters (Fig. 1b) . All clusters exhibited high expression of key marker genes of ILCs, while markers of other cell types were minimally expressed, except for CD3 genes (Extended Data Fig. 1j ; Cd3d), which have previously been observed at the mRNA level in ILCs 17, 18 . ILC1s, ILC2s and ILC3s largely partitioned into distinct clusters. ILC1s composed approximately 50% of cluster 1 (392 cells; 56% of ILC1s), ILC3s and mixed ILCs each made up around 25% of cluster 2 (926 cells; 64% of ILC3s), and the remaining clusters (22,869 cells) were predominantly composed of ILC2s, particularly clusters 3-5 and 8-11 (Fig. 1c, Extended Data  Fig. 1k ). Cluster assignment is strongly associated with treatment (χ 2 test, P < 2.2 × 10 −16
): most cells in clusters 7 and 9-11 are IL-33-activated ILCs, while cells in clusters 5 and 8 are primarily IL-25-activated ILCs, and control ILC2s comprise approximately 90% of clusters 3 and 4 (Fig. 1d, Extended Data Fig. 1l ).
Alarmin-activated ILCs express 1.5-2.5-fold more genes than do resting ILCs, partly owing to proliferation, particularly among IL-33-activated ILC2s (Extended Data Fig. 1c ). Clusters 7 and 11, enriched with such cells, scored highly for a proliferative gene signature (t-test, Type 2 innate lymphoid cells (ILC2s) both contribute to mucosal homeostasis and initiate pathologic inflammation in allergic asthma. However, the signals that direct ILC2s to promote homeostasis versus inflammation are unclear. To identify such molecular cues, we profiled mouse lung-resident ILCs using single-cell RNA sequencing at steady state and after in vivo stimulation with the alarmin cytokines IL-25 and IL-33. ILC2s were transcriptionally heterogeneous after activation, with subpopulations distinguished by expression of proliferative, homeostatic and effector genes. The neuropeptide receptor Nmur1 was preferentially expressed by ILC2s at steady state and after IL-25 stimulation. Neuromedin U (NMU), the ligand of NMUR1, activated ILC2s in vitro, and in vivo co-administration of NMU with IL-25 strongly amplified allergic inflammation. Loss of NMU-NMUR1 signalling reduced ILC2 frequency and effector function, and altered transcriptional programs following allergen challenge in vivo. Thus, NMUR1 signalling promotes inflammatory ILC2 responses, highlighting the importance of neuro-immune crosstalk in allergic inflammation at mucosal surfaces. P < 2.2 × 10 −16 ) ( Fig. 1e ) 19, 20 . Consistent with this, IL-33 induced more robust proliferation of ILCs in vitro than did IL-25 (Extended Data Fig. 2 ).
To uncover novel molecular cues that regulate ILC responses, we identified genes that were differentially expressed across clusters by fitting gene counts to mixtures of generalized linear models that account for variation in both dropout rates and proliferation (Methods, Supplementary Table 1) . Highly differentially expressed genes include both those with known and novel roles in ILC biology (Fig. 1f) . Among known genes, Arg1, Il13 and Klrg1 are highly expressed in clusters where alarmin-activated ILC2s are predominant. Other genes discriminate between cells activated by a single alarmin. For example, clusters 5 and 8 both consist predominantly of IL-25-activated ILC2s, yet Ms4a4b is expressed only in cluster 8. Similarly, Ctla4 was induced only in certain clusters of IL-25-or IL-33-activated cells (Fig. 1f) .
We validated the expression patterns at the protein level for a number of genes using flow cytometry (Extended Data Fig. 1m ). As predicted, KLRG1, gp49 (Lilrb4a), and Batf were upregulated after activation by IL-25 and IL-33. Expression of semaphorin 4a (Sema4a) was reduced in IL-33-activated ILCs, mirroring the lower expression in IL-33-dominant scRNA-seq clusters. Finally, consistent with the scRNA-seq data, only a subset of ILCs upregulated CTLA4 or MHC class II after alarmin activation. These results suggest that distinct functional states exist within defined ILC subsets, and that IL-33 and IL-25 differentially regulate these states.
Studies in other systems have shown that analysis of large cell numbers, even at shallow coverage, can readily identify markers of transcriptional states 14, 21 . However, the number of distinct transcripts per cell in droplet-based scRNA-seq may be lower than in full-length protocols 22, 23 . To explore the possible impact of these differences, we complemented our droplet-based survey with an analysis using a platebased full-length protocol 23 . We analysed 606 high-quality full-length scRNA-seq profiles of ILCs from phosphate-buffered saline (PBS)-, IL-25-, or IL-33-treated mice (Fig. 2a, Extended Data Fig. 3a) . Most cells were classified as ILC2s, consistent with our droplet-based atlas (Extended Data Fig. 3b-e) . The two datasets were highly concordant in terms of the similarity of expression profiles (Extended Data Fig. 4a ), clustering (Fig. 1a, b versus Fig. 2a, b) , and top genes identified by principle component analysis (PCA) or differential expression analysis (for example, Lpcat2, Anxa2, Lgals3bp, Ms4a4b) (Fisher's exact test, P < 3.74 × 10 −80
, for PCA genes) (Figs 1f, 2c ).
Of the differentially expressed genes in plate-based scRNA-seq, Nmur1 (also known as Gpr66 and FM-3) was highly expressed in ILC2s at steady state and after IL-25 stimulation, but was downregulated by IL-33 (Fig. 2c) , and yet was essentially absent in the initial droplet-based scRNA-seq analysis (Extended Data Fig. 4a) . Alignment of bulk, fulllength RNA-seq indicated that the Nmur1 transcript extends to a different 3′ end in lung ILCs than is annotated in the reference transcriptome (Extended Data Fig. 4b ). Upon correcting the Nmur1 annotation, Nmur1 was recovered in the droplet-based data (Extended Data Fig. 4c ). By contrast, Rapgef4, another of the few differentially expressed genes absent in the droplet-based data, has an annotated 3′ end consistent with the bulk RNA-seq, indicating that technical issues other than transcriptome annotation also contribute to discrepancies (Extended Data  Fig. 4d ). Overall, however, both droplet and plate data supported the same global trends, including the differential expression of Nmur1.
ILC2-specific expression of NMUR1
NMUR1 is a receptor for the neuropeptide NMU, and NMU-NMUR1 signalling modulates inflammatory responses 24 , although the role of 
Cd3d
Ms4a4b Ccl5 this pathway in ILCs was unknown. We found that Nmur1 expression was largely specific to ILCs, compared to other lung-resident cell populations. It was highly expressed in ST2
+ ILCs both at steady state and after induction of airway inflammation with house dust mite (HDM) extract (Fig. 2d) . In either setting, the only non-ILC population with detectable Nmur1 expression was CD4 + T cells, which expressed very low levels both after HDM-challenge in vivo, as well as after T helper 2 (T H 2) differentiation in vitro (Fig. 2d, Extended Data  Fig. 5a ). Nmur2, the other known receptor for NMU, was not detectably expressed in lung-resident cells, including ILCs, but was expressed in the central nervous system, as previously reported (Extended Data Fig. 5b) 25-27 . We assessed NMUR1 protein expression by flow cytometry of cells from heterozygous Nmur1-LacZ reporter mice. Approximately 40% of ST2 + ILCs expressed NMUR1 (Fig. 2e, Extended Data Fig. 5c ). Only ILC2s had notable specific staining, although several myeloid cell types demonstrated non-specific staining independent of the reporter allele (Extended Data Fig. 5d ). Treatment in vivo with IL-25 did not alter the frequency of NMUR1 + ILCs, whereas IL-33 markedly reduced their frequency (Fig. 2f) . Regardless of alarmin treatment, NMUR1 was predominantly expressed by ST2 + ILCs and did not correlate with expression of IL-17RB, the receptor for IL-25 (Extended Data Fig. 5e ).
ILCs express several neuropeptide receptors in addition to NMUR1 28, 29 , raising the possibility that neurons communicate directly to ILCs. Immunofluorescence microscopy showed that around 70% of CD3 -KLRG1 + cells are within 10 μm of SNAP-25 + nerve fibres (Extended Data Fig. 6a ). The nodose/jugular ganglion and thoracic dorsal root ganglia (DRG) both contain sensory afferent neurons innervating the lung 28, 30 , and neurons in the DRG, although not in the nodose/jugular ganglion, express Nmu (Extended Data Fig. 6b ). Additionally, IL-13 induced upregulation of Nmu in cultured DRG neurons, suggesting ILCs may also communicate with neurons (Extended Data Fig. 6c ).
NMU amplifies IL-25-driven inflammation
We next investigated whether NMU affected ILC production of type 2 cytokines in vitro. While NMU did not affect cytokine expression by T H 2 cells (Extended Data Fig. 7a ) and only mildly upregulated Il5 and Il13 in cultured ILC2s, NMU markedly increased their mRNA and protein expression when combined with IL-25, suggesting that NMU modulates ILC2 responses to alarmins (Fig. 3a, b , Extended Data Fig. 7b ). The combination of IL-33 and NMU also increased IL-5 and IL-13 expression, but to a lesser extent than IL-25 combined with NMU (Extended Data Fig. 7c) .
The synergy between IL-25 and NMU was even more notable in vivo. NMU alone did not increase expression of Il5 or Il13 mRNA in lung tissue, and only trace quantities of IL-5 protein were detectable in the bronchoalveolar lavage fluid (BALF), consistent with a small increase in BALF eosinophils (Extended Data Fig. 7d-h ). IL-25 modestly induced expression of IL-5 and IL-13 in the lung and BALF, while the combination of IL-25 and NMU strongly increased their expression (Fig. 3c, Extended Data Fig. 7i ). Moreover, IL-25 combined with NMU increased lung and BALF eosinophilia, and markedly enhanced histopathologic evidence of inflammation (Fig. 3d , e, Extended Data Fig. 7j ). Finally, IL-25 combined with NMU induced significant airway hyper-reactivity (Fig. 3f) . In summary, NMU converted a nonpathologic dose of IL-25 into a pathologic one.
To understand the role of endogenous NMU in ILC function, we analysed ILCs in NMU-deficient (Nmu-knockout) mice. At steady state, both the overall frequency of ILCs and ILC expression of KLRG1, ST2, IL-5, and IL-13 were unchanged in Nmu-knockout versus wild-type mice (Extended Data Fig. 8a-c ). After challenge with HDM, total cell numbers and eosinophil frequencies in BALF were similar in wild-type and Nmu-knockout mice (Extended Data  Fig. 8d) . However, the frequency of ST2 + ILCs after HDM challenge was reduced in Nmu-knockout mice, compared to wild-type mice (Fig. 3g) , and a lower percentage of ILCs expressed IL-5 and IL-13 ex vivo (Fig. 3h) . The frequency of lung-infiltrating CD4 + T cells was higher in Nmu-knockout mice, while the frequency of T cells expressing type 2 cytokines ex vivo was unchanged, suggesting potential adaptive immune compensation that could explain the similar degree of BALF eosinophilia (Extended Data Fig. 8e, f) . Overall, the reduced frequency of ILC2s expressing effector cytokines after allergen challenge in Nmu-knockout mice indicates that NMU promotes ILC activation and effector function.
IL-25 combined with NMU expands inflammatory ILC2s
To characterize how IL-25 and NMU synergistically promote allergic inflammation, we profiled lung-resident ILCs by scRNA-seq after in vivo treatment with NMU alone or in combination with IL-25 (Fig. 4a , Extended Data Fig. 9a, b) . NMU-treated ILCs were transcriptionally similar to control ILCs, consistent with the minimal in vivo impact of NMU alone (Fig. 4a) , whereas the expression profiles of ILCs treated with a combination of IL-25 and NMU were distinct from those of IL-25-and NMU-treated ILCs, and comparable to those of IL-33-activated ILCs (Extended Data Fig. 9c ). We analysed profiles from ILCs treated with PBS, NMU, IL-25 and IL-25 combined with NMU, partitioning them into 11 clusters (Fig. 4b ). There was a significant association between cluster and treatment (χ 2 test, P < 2.2 × 10
−16
). Five clusters (6 and 8-11) consisted almost exclusively of cells activated by IL-25 or IL-25 combined with NMU (Extended Data Fig. 9d, e) , ). Finally, IL-17RB + ILC frequency after HDM challenge was reduced in Nmu-knockout versus wild-type mice ( Fig. 4g ), suggesting that NMU potentiates ILC responsiveness to IL-25 following both allergen challenge and alarmin stimulation.
We analysed differential gene expression between IL-25 combined with NMU and other conditions, focusing on genes with a non-additive pattern of expression. One subset of such genes, including Il1r2, Tnfrsf8 (CD30) and Mt1, was strongly upregulated specifically by IL-25 combined with NMU ( Fig. 4h) . A second subset, including Zfp36l1 and Csf2, was downregulated by IL-25 combined with NMU, even though it was upregulated after treatment with IL-25 and/or NMU alone. Finally, a few genes (for example, Btg2 and Fosb) were expressed at steady state and in single-treatment conditions at similar levels, but were downregu lated by IL-25 combined with NMU. We validated these expression patterns for several representative genes by flow cytometry.
Consistent with the scRNA-seq data, both CD30 and IL-1R2 were upregulated only by IL-25 combined with NMU; galectin-3 (Lgals3) and gp49 (Lilrb4a) were upregulated by either NMU or IL-25 alone and further induced by IL-25 combined with NMU; and NR4A1 expression was highest in response to IL-25 alone (Extended Data Fig. 9i) .
Several of these genes have previously been linked to allergic airway inflammation in both mice and humans. Mice lacking Tnfrsf8 and Anxa2 have reduced airway inflammation in asthma models 31, 32 . Tnfrsf8, Anxa2 and Il1r2 are overexpressed in allergic asthmatics [33] [34] [35] . Deletion of Nr4a1, which is downregulated by IL-25 combined with NMU, exacerbates airway inflammation in mice, suggesting a potential role in limiting inflammatory ILC responses 36 .
Cluster-based analysis of differentially expressed genes further highlighted that ILCs from mice treated with IL-25 combined with NMU were transcriptionally heterogeneous (Fig. 4b, Extended Data Fig. 9j ). Some genes, such as Il13, were highly expressed in all clusters principally composed of ILC2s treated with IL-25 combined with NMU or IL-25 (clusters 6-11), while other genes were specific to certain clusters. For example, Ifitm3 was highly expressed in ILCs in cluster 10, whereas ILCs in cluster 7, which were also expanded by IL-25 combined with NMU, co-expressed key antigen-presentation genes, including MHC class II (for example, H2-Ab1) and the invariant chain (Cd74). IL-25 combined with NMU also increased the frequency of a population of MHC-II hi ILCs as determined by flow cytometry (Extended Data Fig. 9i . ILCs of cluster 8 also expressed Nmur1, as did cells in IL-25 predominant cluster 6, suggesting that these two subsets are preferentially NMUresponsive. Flow cytometry revealed that NMUR1 was expressed by IL-25-treated ILCs, including iILC2s (Extended Data Fig. 9k ). While both IL-25 combined with NMU and IL-33 downregulated NMUR1 on ILC2s, IL-25 combined with NMU uniquely expanded the population experiments. f, Frequency of Il17rb-expressing ILCs determined by scRNA-seq; *P < 2.73 × 10 −10 , logistic regression. g, IL-17RB + ILC frequency after HDM challenge as determined by flow cytometry. h, Differentially expressed genes (y axis) by condition (x axis). Data points in c, e, g are individual mice (in c: PBS, n = 3; IL-25, n = 9; IL-25 combined with NMU, n = 7; in e: IL-25, n = 8; IL-25 combined with NMU, n = 6; in g: wild-type, n = 5; Nmu-knockout, n = 5). Mean is indicated. Error bars, s.e.m.; *P < 0.05 by one-way ANOVA (c) or two-tailed t-test (d, e, g).
of iILC2s, suggesting that NMU-NMUR1 signalling preferentially modulates the activation and/or expansion of certain IL-25-induced iILC2 subsets (Extended Data Fig. 9l, m) .
NMUR1 promotes ILC2 activation by HDM
To further characterize the impact of NMUR1 signalling on ILCs, we challenged wild-type and Nmur1-knockout mice with HDM and profiled lung-resident ILCs by scRNA-seq. Analysis of 21,895 high-quality profiles largely clustered them by in vivo treatment, regardless of genotype or batch (Fig. 5a, Extended Data Fig. 10a, b) . In Nmur1-knockout mice, ILC2 frequency was markedly reduced after HDM challenge compared to PBS (76% versus 91%; multinomial logistic, P < 2.2 × 10 −16 ), exaggerating a trend also seen in wild-type mice (87% versus 94%, multinomial logistic, P < 2.2 × 10
), which is consistent with the reduced frequency of ST2 + ILCs in Nmu-knockout mice after HDM challenge (Fig. 5b, Extended Data Fig. 10c, d ). While IL-25 combined with NMU and IL-33 induced robust proliferation and increased ILC2 frequency, HDM challenge only induced a high proliferation score in the cells of one small cluster (cluster 6, 210 cells) (Fig. 1e, Extended Data Figs 1e, 10e-h ). This minimal induction of proliferation, in conjunction with an increase in ILC1s and ILC3s, may be related to the observed reduction in ILC2 frequency after HDM challenge.
Based on genes differentially expressed between HDM-and PBStreated wild-type ILC2s, we defined an inflammatory ILC2 signature ( Fig. 5c-e) . ILCs from mice treated with IL-25 combined with NMU scored highly for this inflammatory signature, suggesting that it identifies inflammatory ILC2s independent of the model of airway inflammation (Fig. 5d, e) . Differentially expressed genes in ILC2s from HDM-treated mice significantly overlapped with those in ILCs from mice treated with IL-25 combined with NMU (Fisher's exact test, P < 1.64 × 10 −25 ). Finally, Nmur1-knockout ILC2s had a lower average inflammatory score than wild-type ILC2s after HDM challenge (t-test, P < 4.9 × 10 −15 ), consistent with NMU-NMUR1 signalling promoting ILC2 responses in vivo (Fig. 5e ).
Discussion
We used massively parallel droplet-based scRNA-seq to establish the transcriptional landscape of lung-resident ILCs under homeostatic and inflammatory conditions, and identified NMUR1 as a modulator of alarmin-and allergen-driven ILC2 responses. Nmu-knockout mice were previously reported to develop attenuated airway inflammation after allergic sensitization 24 , but the underlying mechanism was unclear. NMU expression in bronchial brushing samples from asthmatic patients correlates with disease severity, which our data suggests could be related to the effect of NMU on ILC function 37 . Functional analysis and scRNA-seq-based approaches both demonstrate that, in the absence of NMU-NMUR1 signalling, ILC2s are decreased in frequency and have impaired effector function after allergen challenge. Although the inflammatory signature score of allergen-challenged NMUR1-deficient ILC2s is significantly decreased compared to allergenchallenged wild-type ILC2s, it is still increased compared to PBStreated controls, suggesting that other factors, in addition to NMU, contribute to ILC activation in this context.
Our findings raise the question of whether NMU potentiates airway inflammation when high levels of alarmins, such as IL-25, are present, as is the case in steroid-naive T H 2-high asthma or postviral asthma exacerbations 1, 38 . While airway epithelial cells upregulate IL-25 in response to stress, chemosensory cells, which are found in both the intestine and trachea, constitutively produce IL-25 and modulate mucosal immune responses [39] [40] [41] [42] [43] . Our observation that NMU is expressed by neurons from thoracic DRG suggests that the coordinated action of neurons and chemosensory cells could promote tissue-based, ILC-dependent type 2 immune responses. Given the importance of smooth muscle contraction in the clinical manifestations of allergic diseases, it is intriguing that NMU can induce both smooth muscle contraction 44 and ILC2-driven inflammation. Neuronal activation following inhalation of noxious substances or allergens could potentially trigger both processes, simultaneously promoting physical expulsion and allergic immunity to the provoking stimulus. Taken together, our findings demonstrate a novel neuro-immune pathway that exacerbates mucosal allergic inflammation in vivo.
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Mice and in vivo ILC activation. C57Bl/6J mice were purchased from the Jackson Laboratory. Nmur1-LacZ reporter mice with a LacZ cassette knocked into the Nmur1 locus were rederived from Nmur1 tm1.1(KOMP)Vlcg sperm obtained from the trans-NIH Knockout Mouse Project (KOMP) Repository. NMU-deficient mice (Nmu-knockout) were rederived from B6.129S2-NMU < tm1Mko > embryos from the RIKEN BioResource Center. For experiments with Nmur1-LacZ (Nmur1-knockout) and Nmu-knockout mice, littermates that were either homozygous or heterozygous for the wild-type allele were used as controls. Mice were housed under specific-pathogen-free conditions. For experiments, mice were matched for sex and age, and most mice were 6-10 weeks old. Where indicated, mice were anaesthetized with isoflurane and treated intranasally with the indicated stimuli (500 ng IL-25, 500 ng IL-33, or 20 μg neuromedin U) daily for three consecutive days. The total administered volume was 20 μl for all conditions. Mice were randomly assigned to treatment groups after matching for sex and age. Airway inflammation was also induced with house dust mite (HDM) extract (Greer Laboratories). Mice were treated intranasally with 10 μg HDM on day 0, 7, 8 and 9, before being euthanized on day 10. No power analysis was performed. The investigators were not blinded to allocation during experiments and outcome assessment except for the severity score of airway inflammation. All experiments were conducted in accordance with animal protocols approved by the Harvard Medical Area Standing Committee on Animals or BWH IACUC. Lung analysis. Mice were euthanized and perfused with cold PBS. Where indicated, after perfusion, broncho-alveolar lavage (BAL) was obtained by injecting 1.5 ml cold PBS into the lungs via a secured tracheal cannula. BALF was centrifuged, and the supernatant was used for analysing cytokine levels and the cell pellet was resuspended, counted, and used for flow cytometry. Following BAL, lung lobes were dissected. The post-caval lobe was fixed in buffered formalin for histological analysis. Single cell suspensions of the remaining lung parenchymal tissue were prepared with the GentleMACS lung dissociation kit (Miltenyi Biotec) according to the manufacturer's instructions. Where indicated, cells were diluted in 10% Trypan Blue and viable cells counted using a hemocytometer. RNA-seq. For population (bulk) RNA-seq, sorted ILCs were lysed with RLT Plus buffer and RNA was extracted using the RNeasy Plus Mini Kit (Qiagen). Fulllength RNA-seq libraries were prepared as previously described 45 and paired-end sequenced (75 bp × 2) with a 150 cycle Nextseq 500 high output V2 kit.
For droplet-based 3′ end massively parallel single-cell RNA sequencing (scRNA-seq), sorted ILCs were encapsulated into droplets, and libraries were prepared using Chromium Single Cell 3′ Reagent Kits v2 according to manufacturer's protocol (10× Genomics). The generated scRNA-seq libraries were sequenced using a 75 cycle Nextseq 500 high output V2 kit.
For full-length scRNA-Seq, single ILCs were sorted into 96-well plates containing 5 μl TCL Buffer (QIAGEN) with 1% 2-mercaptoethanol, centrifuged and frozen at −80 °C. SMART-Seq2 protocol was carried out as previously described 23 with minor modifications in the reverse transcription step (M.S.K. and A.R., in preparation). cDNA was amplified with 22 cycles and tagmented with one-eighth of the standard Illumina NexteraXT reaction volume. Single-cell libraries were pooled and paired-end sequenced (38 bp × 2) with a 75 cycle Nextseq 500 high output v2 kit.
All RNA-seq data represent pooled data from at least two distinct biological replicates. ILC in vitro culture. For in vitro experiments 5,000 ILCs per well were cultured in a 96-well round bottom plate with 20 ng ml −1 IL-7 (R&D Systems), 200 ng ml
IL-25 (R&D Systems) or 20 ng ml −1
, 2 ng ml −1 or 0.2 ng ml −1 IL-33 (BioLegend) with or without 1 μg ml −1 neuromedin U (US Biological). In some cases purified CD90.2 + lung cells were first labelled with CellTrace Violet (Thermo Fisher Scientific), then sorted as described above, and cultured for three days under the indicated conditions. Histology. Following paraffin embedding, sections of the formalin-fixed lung lobe were stained by H&E staining. Tissue sections were scored by a histopathologist in a blinded manner for severity of lung inflammation according to the following scoring system: 0, normal; 1, very mild; 2, mild; 3, moderate; 4, severe. Methacholine challenge. Airway hyper-responsiveness was determined as previously described 28 using a flexiVent rodent ventilator (SciReq). LacZ reporter assay. The Nmur1 null allele contains a LacZ reporter cassette. Single-cell suspensions of lung cells from Nmur1-LacZ +/− mice were stained with the FluoReporter lacZ flow cytometry kit (Thermo Fisher Scientific) according to the manufacturer's protocol. Immediately after fluorescein di-V-galactoside (FDG) loading was stopped with 1.8 ml ice-cold medium, cells were stained with 7AAD and antibodies against surface markers and analysed by flow cytometry. Quantitative real-time PCR. RNA was isolated using RNeasy Plus Mini Kit (Qiagen) and reverse transcribed to cDNA with iScript cDNA Synthesis Kit (Bio-Rad). Gene expression was analysed by quantitative real-time PCR on a ViiA7 System (Thermo Fisher Scientific) using TaqMan Fast Advanced Master Mix (Thermo Fisher Scientific) with the following primer/probe sets:
and Actb (Applied Biosystems). Expression values were calculated relative to Actb detected in the same sample by duplex qPCR. Cytokine quantification. Cytokine concentrations in BAL fluid, lung and supernatant of in vitro ILC cultures were analysed by the LegendPlex Mouse Th Cytokine Panel (13-plex) (BioLegend) according to the manufacturer's instructions and analysed on a FACS Calibur (BD Biosciences). T cell in vitro culture. CD4 + T cells were isolated as described previously 46 and sorted for naive T cells (CD4 + CD62L + CD44 low ) on a FACS Aria. Naive T cells were cultured in the presence of plate-bound anti-CD3 (1 μg ml −1 ; Bio X Cell) and anti-CD28 (1 μg ml −1 ; Bio X Cell) antibodies. T H 2 cells were generated by addition of 20 ng ml −1 IL-4 (Miltenyi Biotec) and 20 ng ml −1 anti-IFNγ (Bio X Cell) antibody. On day 3 of in vitro differentiation, PBS, 200 ng ml −1 IL-33 (BioLegend) or 100 ng ml −1 IL-25 (R&D Systems) were added to the T cell culture either with or without 1 μg ml −1 NMU (US Biological). After 2 additional days, RNA was isolated. Nodose/jugular and dorsal root ganglion isolation and cultures. Nodose/ jugular ganglion and dorsal root ganglia (DRG) were dissected from mice and dissociated in 1 mg ml −1 collagenase A with 3 mg ml −1 dispase II (Roche Applied Sciences) in HEPES buffered saline (Sigma) for 60 min at 37 °C. For some experiments, cells were then lysed in RLT Plus buffer and RNA was isolated using the RNeasy Plus Mini Kit (Qiagen). For the purposes of cell culture, the DRG cell suspension was then triturated with glass pasteur pipettes of decreasing size, followed by centrifugation over a 12% BSA (Sigma) gradient. After centrifugation, the top layer of neuronal debris was discarded and the DRG pellet was resuspended in neurobasal (NB) media containing B-27 and penicillin/ streptomycin (Life Technologies). DRGs were then plated on laminin-coated 96-well culture dishes in NB media with B27, 50 ng ml −1 nerve growth factor (NGF) and penicillin/ streptomycin. The next day the cells were washed with PBS before addition of fresh NB media containing B-27, NGF and penicillin/streptomycin. DRG cultures were stimulated with 200 ng ml −1 IL-13 for 30 min, at which time RNA was isolated for qPCR analyses. Immunofluorescence microscopy. Mice were perfused with 37 °C PBS via the heart. The lungs were extracted and inflated via the trachea with 4% low melting agarose (16520-100; Invitrogen) and fixed in 4% PFA on ice for 1 h. The lungs were embedded in agarose for vibratome cutting (Leica). 100-μm lung slices were Article reSeArcH blocked first with the mouse on mouse blocking reagent (Vector Laboratories) and subsequently with 5% goat and donkey serum (Jackson ImmunoResearch) in PBS/0.1% Triton X-100. Tissue was stained for rat anti-CD3ε (17A2; BioLegend), hamster anti-KLRG1 (2F1; eBioscience) and mouse anti-SNAP-25 (SMI81; BioLegend) overnight at 4 °C shaking. After washing in PBS, tissues were incubated at room temperature for 1 h in in PBS/0.1% Triton X-100 containing goat anti-rat-AF555, goat anti-hamster-AF647, or goat anti-mouse IgG1-AF488 (all ThermoFisher Scientific) and then washed again. Images were acquired with an inverted Nikon Eclipse Ti microscope (Nikon). Z-stacks were acquired and converted into all-in-focus images using the Extended Depth of Focus (EDF) plug-in (NIS-Elements). Distances of KLRG1 + CD3ε − cells to the closest SNAP-25 + nerve fibre were measured using the NIS-Elements software. Statistical analysis of functional data. No data were excluded from analysis. Prism 7 (GraphPad Software) was used to perform two-tailed t-test and ordinary one-way or two-way ANOVA with Tukey's multiple comparisons test on datasets for which statistical significance is indicated (except the RNA-sequencing data). All figures of functional data show mean ± s.e.m. P values in transcriptomic analysis. For certain types of numeric computations, the smallest P value that R can report is <2.2 × 10 −16
. Analysis of droplet-based scRNA-seq samples: initial QC. Gene counts were obtained by aligning reads to the mm10 genome using CellRanger software (v1.2 for data from alarmin-treated and NMU-treated mice, v1.3 for data from HDMtreated mice) (10× Genomics), with the genome re-annotated at the 3′ end of Nmur1 (see main text). To remove doublets and poor-quality cells, cells were excluded from subsequent analysis if they were outliers in their sample of origin in terms of number of genes, number of unique molecular identifiers (UMIs), and percentage of mitochondrial genes (Extended Data Fig. 1b, c) . The number of UMIs per cell and number of genes expressed per cell are tightly correlated with condition (Extended Data Fig. 1c) , probably due to the effect of proliferation on transcript numbers. Sample-specific cut-offs ranged from 626-2,483 genes per cell for a PBS-treated sample to 1,502-5,260 genes per cell for an IL-33 treated sample. At least 92% of cells were retained for each sample.
To further estimate and remove technical variability from the overall increased variability across replicates in group C (defined below), additional QC measures were taken (Extended Data Fig. 10a, b) . UMI and gene saturation were estimated independently for each cell by subsampling a fraction of the total number of reads, with replacement, across a range of fractions (0.02 to 0.98, in 0.02 increments). For each subsample, we calculated the number of UMIs and transcripts detected. The sampling procedure was repeated ten times, and the values were used to estimate saturation limits for UMI/genes by nonlinear fitting of the following saturation function: y = ax/(b + x) + c. Cells were removed if they were outliers with respect to estimated saturation for either genes or UMIs. Cells were also removed if they were outliers in terms of the ratio or relative difference of the total number of UMIs with the number of unique UMIs. After all QC, 73-83% of cells in each of these samples were retained.
Parts of the subsequent analysis used the R package Seurat 47 , version 1.4.0.7, which includes sparse matrix support for large datasets. To normalize gene counts while accounting for widely varying UMI counts among conditions, we used a scaling factor reflecting the expected number of UMIs in each condition. To verify that the dataset consists of ILCs, we checked the raw counts for the expression of major markers of other immune cell groups (Extended Data Fig. 1j ). For subsequent analysis, genes expressed in less than 0.1% of cells were excluded. Analysis of droplet-based scRNA-Seq samples: signature scores. We calculated signature scores as the log of the geometric mean of the TPX values for the genes in the signature. That is, let S be a set of m genes defining a signature, and for any gene g in S and a given cell, let x g be the expression of g in the cell in TPX. Then the signature score for that cell is calculated as
which is equivalent to the arithmetic mean of the logTPX values. Actual expression values, rather than centred or z-scored expression values were used. For several of our signatures, centreing (or z-scoring) expression values before computing signatures leads to misleading scores that are close to 0 across the whole dataset, though the corresponding gene expression is high. This is in part due to ILC2s composing the majority of the cells, and hence genes that are highly expressed by ILC2s lack sufficient variance over the dataset to be useful in a mean-centred signature.
We also did not replace these scores with a statistical comparison of them to randomized signatures selected from a null distribution (in contrast to our other studies 20, 45 ). Owing to the varying proliferative responses in our cells, it is difficult to find a true null set of signatures, even after matching genes for dataset-wide mean and variance profiles. Signature scores are thus calculated in a way that is independent of the expression levels of unrelated genes in the same cell, and may be interpreted as similar to, though less noisy than, single-gene expression values.
The ILC subset signatures (ILC1, 2, 3 as used in Figs 1c , 5b, Extended Data Figs 1d-g, k, 3b-e, 10c-e) were curated based on established markers for ILC subsets (Supplementary Table 2 ). The proliferation signature was created by combining our previously published gene signatures 19, 20 that define G1-S and G2-M phases (Supplementary Table 2 ). For both ILC subset and proliferative signatures, all genes contribute positively to the signature score. For the inflammatory ILC2 signature, differentially expressed genes contribute positively to the score if they are upregulated in ILC2s from wild-type mice after HDM stimulation relative to PBS, and negatively otherwise (Supplementary Table 1) . Analysis of droplet-based scRNA-Seq samples: assigning ILC type. ILC signatures were used to assign each cell to one of the following categories: ILC1, ILC2, ILC3, 'mixed' (scoring highly for multiple ILC types), and 'none' (not scoring highly for any ILC type) (Supplementary Table 2 ). The frequency of mixed type ILCs (2.6%) is comparable to the expected doublet rate (3-4%). Based upon the dip in the bimodal distributions of ILC subset signature scores (Extended Data  Figs 1d, 3b, 10c, d ), the minimum score for assignment to a given category was set to 0.08. To be uniquely assigned to a category, the ratio of the highest score to the next highest score was required to be at least 1.25. The analysis is not sensitive to the specific ratio threshold choice of 1.25; that selection was made to balance the trade-off between the purity of the transcriptional profile of cells assigned to one of the three ILC subtype populations, and the number of cells called as mixed.
To test the strength of association between ILC type and treatment conditions, we used the R package nnet, version 7.3-12, to do a multinomial logistic regression on the ILC type, with replicate and condition as predictors. Analysis of droplet-based scRNA-Seq samples: PCA, clustering, and tSNE. Variable genes were then selected using the MeanVarPlot function in Seurat with the x.low.cutoff and y.cutoff parameters set to 0.05 and 0.7, respectively, resulting in gene sets of size 774 (group A), 723 (group B), and 475 (group C). PCAFast was run on mean-centred variable genes to compute a limited number of PCs. To select the number of PCs to include for subsequent analysis, we estimated the number of eigenvalues larger than would be predicted by a null distribution for random matrices (Marchenko-Pastur law), and also assessed the decrease in marginal proportion of variance explained with larger PCs. The top 22 (groups A, B) and 13 (group C) PCs were included for subsequent analysis. We confirmed that the resulting analyses were not particularly sensitive to this exact choice.
The cells were clustered via Seurat's FindClusters function, which optimizes a modularity function on a k-nearest-neighbour graph computed from the top eigenvectors. After a range of cluster resolution parameters were tested, 0.6 (groups A and B) and 0.5 (group C) were selected because resulting clusters captured major, condition-related divisions, known subgroups, and statistically validated transcriptional distinctions of interest, while avoiding subdivisions of relatively uniform parts of the data.
To visualize the data, tSNE plots were created by calling Seurat's RunTSNE function, with the dims.use parameter set to the selected number of PCs and the do.fast parameter set to TRUE. A number of perplexity para meter choices were evaluated before selecting 100 (group A) and 50 (groups B and C). These perplexity settings produced tSNE plots that reflected the cluster structure found independently of tSNE, without introducing extreme artefacts. tSNE plots of cells separated by batch indicate that experimental batches appear to have a rela tively minor impact on the PCA and clustering (Extended Data Figs 1h, 9b, 10b) . Analysis of droplet-based scRNA-seq samples: differential gene expression. To avoid spurious results due to cells in different conditions or clusters having vastly . The model requires a substantial amount of data to fit, making it well suited to data generated by massively parallel methods. As an alternative to the zero-inflated negative binomial, we also performed a logistic regression by fitting a generalized linear model using the binomial family with a logit link, with the same covariates.
DE tests included the following models: (1) a cluster-based model with indicator coefficients for each cluster except the reference PBS-dominated cluster (groups A, B, and C); (2) a condition-wide model with indicator coefficients for each condition (with the PBS condition as reference) (groups A, B, and C); and (3) a direct comparison of IL-25 versus IL-33, with IL-33 as reference (group A); (4) a condition-based model with indicator coefficients for NMU and IL-25, and an additional interaction term (with the PBS condition as reference) to detect non-additive effects (group B); (5) a direct comparison between IL-25 combined with NMU and IL-25, with IL-25 as reference (group B). In group C, we restricted the DE analysis to the cells transcriptionally classified as ILC2s, in order to identify difference in these particular cells, without the analysis being driven by the change in relative proportions of ILC1s and ILC3s compared to ILC2s after HDM treatment.
Many cell-cycle genes and ribosomal protein genes are differentially expressed across conditions and clusters, particularly if there is a difference in proliferation. To detect other differentially expressed genes as well, before ranking DE results, we removed ribosomal protein genes and (in all cases except group C, where it was not needed) the genes in the proliferation signature (Supplementary Table 2) .
DE tests report coefficients and associated P values for each variable of interest (for example, cluster or condition), separately for each model component. To rank the results for any given model, we created a list of differentially expressed candidate genes that are detected in at least 10% (15% for group C) of the cells in one of the groups in the model and have a coefficient for a term of interest with absolute value at least 0.5 (0.75 for group C) and corresponding FDR-adjusted P value <1 × 10 −20 for condition-wide DE, <1 × 10 −6 for cluster DE, for at least one component. We ranked these candidates by lowest P value and also by largest absolute value of coefficient. The top 25 genes (top 5, 5 and 3 genes for cluster models in groups A, B and C, respectively) genes according to each ranking were reported, with a minimum of 1-2 genes, if available, selected from each of the set of candidates with positive coefficients and the set with negative coefficients. These genes are reported according to the condition or cluster for which they were ranked highly, and the sign reported is 'plus' ('minus') if that condition or cluster has a higher (lower) expression by both fraction of cells expressing and level of expression than the reference, or if these are discordant then the sign is reported as 'NA' (Supplementary Table 1) .
We curated a representative selection from the highest ranked results to represent, in Fig. 1f , common, distinctive patterns across clusters in group A, and, in Fig. 4h , patterns that distinguish IL-25 combined with NMU from the other conditions in group B and highlight nonlinear interactions between NMU and IL-25. To create the inflammatory ILC2 signature (Fig. 5c-e) we used the top-ranked genes differentially expressed between HDM and PBS treatments in ILC2s only in wild-type mice, as well as those differentially expressed in HDM-and ILC2-dominated clusters (5 and 6) in this dataset. The signature genes are reported with the sign positive if the respective condition or cluster has higher expression than the reference for that model (Supplementary Table 1) .
To more broadly compare differentially expressed genes between HDM and IL-25 combined with NMU datasets, we constructed one gene set for IL-25 combined with NMU by taking the top differentially expressed genes for all models and comparisons in group B in which there is a coefficient for the condition IL-25 combined with NMU or a coefficient for a group or cluster to which cells treated with IL-25 combined with NMU contribute (clusters 2, 6-11) (Supplementary Table 1) . We then performed the analogous procedure in the HDM data (including clusters 1-2 and 4-7) (Supplementary Table 1 ). Using as the null set the 12,719 genes shared between groups B and C, we used Fisher's exact test to determine the significance of the overlap of 23 genes between the 156 genes from the IL-25 combined with NMU gene set (151 of which are in the null set) and the 85 genes from the HDM data (all of which are in the null set) (P < 1.64 × 10
−25
). Analysis of SMART-Seq2 plate-based scRNA-seq data. Reads were aligned to mm10 using Kallisto 50 quant, version 0.42.3. The R package tximport 51 , version 1.2.0, was used to convert the output to gene counts and traditional TPM values. Because of the variability in read counts per cell across plates, even from the same condition, as well as in the number of genes per cell across conditions, QC was performed for each of eight plates individually in order to remove cells that were outliers or too low with respect to either measure (Extended Data Fig. 3a) . Out of 752 cells, 606 cells met QC criteria (234 from control, 152 from IL-25-treated mice, and 220 from IL-33-treated mice), and the number of genes per cell in this set ranged from 1,625 to 6,375. Genes that were not expressed with log(TPM) > 2.5 in at least two cells were removed from further analysis. Subsequent analysis proceeded analogously to the droplet-based RNA-seq analysis, with parameter settings that reflected both the wider dynamic range of expression and much smaller cell numbers. The minimum ILC signature score required in ILC type assignment was 0.3. Variable genes were identified by running MeanVarPlot with x.low.cutoff = 0.1, y.cutoff = 1.5, and x.high.cutoff = 10, resulting in a set of 519 genes. PCA was performed on the mean-centred expression of variable genes, with 9 PCs chosen for the subsequent clustering analysis (resolution parameter 0.6). RuntSNE was called with the default perplexity value of 30.
The DE analysis for plate-based data followed the structure of the droplet-based analysis but used only logistic regression, with both a condition-based model and a cluster-based model. To rank the results for each model, we created a list of differentially expressed candidate genes that are detected in at least 30% of the cells in one of the groups in the model and have a coefficient for a term of interest with an absolute value at least 1.0 (for condition-based models) or 1.5 (for cluster models) and corresponding FDR-adjusted P values <1 × 10 −4 (for condition-based models) or <1 × 10 −5 (for cluster models). We ranked the candidates by lowest P value and by largest absolute value of coefficient. The top 40 genes (for condition model) or 3 genes (for cluster model) according to each ranking were reported, with a minimum of 10 genes (for condition model) or 1 gene (for cluster model), if available, selected from each of the set of candidates with positive coefficients and the set with negative coefficients (Supplementary Table 1 ). To create the plot in Fig. 2c , we took a high-ranked illustrative subset of these genes.
To compare plates and droplets, we took as the null set all genes (11,117 genes) detected in both group A from droplet-based data and in plates. For the PCA comparison, we took the union of the highest and lowest 10 (group A) or 20 (plates) genes for the PCs used in each analysis (141 genes from droplet-based data, 202 genes from plate-based data, 66 genes in the intersection), and used Fisher's exact test to determine significance (P < 3.74 × 10
−80
). For the comparison of differentially expressed genes, we used the previously computed sets of top-ranked DE genes for group A (219 genes) and for the plate data (72 genes), and again used Fisher's exact test to determine significance of the overlap (P < 3.91 × 10
−25
). Re-annotation of the 3′ UTR of Nmur1. Initially, Nmur1 had essentially no detected expression in the droplet-based scRNA-seq data, though many reads align to a region just downstream of the Nmur1 3′ UTR annotation (Extended Data Fig. 4b) . To explore the basis of this discrepancy, we aligned long (75 bp) paired-end reads from full-length RNA-seq of population samples that included cells from all three stimulation conditions (only those from IL-25 shown). Many read alignments bridge the annotated Nmur1 transcript and the region downstream where droplet-based 3′ reads align (Extended Data Fig. 4b ), evidence that Nmur1 has isoforms longer than the annotated transcript. We re-annotated the transcriptome, moving the 3′ end from 86,386,242 to 86,384,000, and realigned the droplet-based scRNA-seq data, resulting in a robust increase in frequency of detection of Nmur1. All droplet-based scRNA-seq data shown in this maunscript was aligned to this re-annotated transcriptome. Code availability. Code will be made available upon request. Data availability. The data discussed in this publication have been deposited in the NCBI Gene Expression Omnibus and are accessible through GEO Series accession number GSE102299. Processed scRNA-seq data can be visualized and downloaded at https://portals.broadinstitute.org/single_cell/study/lung-ilcsunder-alarmin-and-neuropepide-activation.
